The frequency of CD4+ CD25+ FoxP3+ CD127‐cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2685-2686
Number of pages	2
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	10
DOIs	https://doi.org/10.1111/all.14342
Publication status	Published - 27 Apr 2020

Access to Document

@article{9afcefe5cc624aa99cad0304cdc37fba,

title = "The frequency of CD4+ CD25+ FoxP3+ CD127‐cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy",

author = "Liam O'Mahony",

year = "2020",

month = apr,

day = "27",

doi = "10.1111/all.14342",

language = "English",

volume = "75",

pages = "2685--2686",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "10",

}

TY - JOUR

T1 - The frequency of CD4+ CD25+ FoxP3+ CD127‐cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

AU - O'Mahony, Liam

PY - 2020/4/27

Y1 - 2020/4/27

UR - http://dx.doi.org/10.1111/all.14342

UR - https://www.scopus.com/pages/publications/85084567479

U2 - 10.1111/all.14342

DO - 10.1111/all.14342

M3 - Article

C2 - 32339292

SN - 0105-4538

VL - 75

SP - 2685

EP - 2686

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 10

ER -